4 completed. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow FLUAD®: new trials by email Literature Review of FLUAD® trials Research Report on FLUAD®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults mRNA-1010, Egg-based Quadrivalent Influenza Vaccine, Adjuvanted Quadrivalent Influenza Vaccine - Influenza | Phase 2 | Completed | ModernaTX, Inc. | 172 | 2022-11-02 | 2025-11-24 |
| A Study of Modified mRNA Vaccines in Healthy Adults mRNA-1273, mRNA-1010, mRNA-1345 - SARS-CoV-2, Seasonal Influenza | Phase 1 | Completed | ModernaTX, Inc. | 308 | 2022-05-24 | 2026-03-12 |
| FLUAD® vs. Fluzone® High-Dose Study FLUAD®, Fluzone® High-Dose - Pain, Quality of Life | Phase 4 | Completed | Duke University | 757 | 2017-08-28 | 2021-03-30 |
| Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus Focetria®, Fluad®, Begrivac® - H1N1 Influenza Virus, Chronic Pulmonary Disease | Phase 3 | Completed | Chiltern Pesquisa Clinica Ltda | 342 | 2010-03-01 | 2013-06-14 |
Influenza, Human (4) · COVID-19 (1) · Coronavirus Infections (1) · Cytomegalovirus Infections (1) · Diabetes Mellitus (1) · Drug-Related Side Effects and Adverse Reactions (1) · Heart Diseases (1) · Injection Site Reaction (1) · Lung Diseases (1) · Pain (1) · Virus Diseases (1)
ModernaTX, Inc. (2) · Chiltern Pesquisa Clinica Ltda (1) · Duke University (1)
United States (3) · Brazil (1)
Elizabeth Barnett, MD (1) · Kenneth Schmader, MD (1) · Theresa Harrington, MD (1)
PMID 33443580, PMID 37393237, PMID 40276503, PMID 41398408, PMID 41535296